OneLife - "enzymes for patients' safety"’s Post

Very important study about the sink as a major contamination factor in hospitals in general and intensive care units specifically. Their are solutions that works with the right cooperation we can create the difference…

Excited to share our latest research in the Bulletin of Atmospheric Science and Technology (Q1, Springer Nature, Scopus indexed) on the effectiveness of negative air ions (NAIs) in improving indoor air quality! 🌿✨ Our study, Effectiveness of a Negative Ion Generator “Instashield” for Indoor Air Disinfection (DOI: 10.1007/s42865-025-00092-3), evaluated the Instashield NAI generator in hospital and GLP-certified laboratory settings with promising results: ✅ Up to 38% bacterial and 77% fungal reduction in a hospital within 1 hour. ✅ Near-total microbial elimination (99.6% bacterial, 100% fungal) in a controlled lab after 36 hours. ✅ Safe CO2 levels and non-invasive air purification, making it a strong alternative to traditional filters and UV sterilization. This study highlights the potential of NAIs in reducing airborne pathogens and enhancing infection control in healthcare, labs, offices, and public spaces. A huge thank you to my co-authors Dr. Vikas Sahu, Dr. Chintala Kavya, Dr. Swathi C. M., Ms. Chandra Sri Durga, Dr. Hima Bindu Mantravadi, Mr. Palavardhan Peddapalegani, and Dr. Kranti Kiran Reddy Ealla for their dedication! Grateful to Mr. C S Jadhav, Mr. Hitesh M Patel, and Aurum Pharma Lab for their support. Looking forward to further exploring NAIs in air disinfection and infection prevention. Let’s keep pushing the boundaries of clean air innovation! 🌬️💡 #Research #AirQuality #HealthcareInnovation #Instashield #NegativeAirIons #IndoorAir #InfectionControl

📢 The Antimicrobial Resistance (AMR) Diagnostic Initiative policy brief is out! The initiative builds on the resolution WHA76.5 (2023) “strengthening diagnostic capacity” adopted by Member States during the Seventy-Sixth World Health Assembly. 🎯 The goal is to enhance diagnostic capacity, improve laboratory systems, and ensure equitable access to quality testing for bacterial, fungal, and resistant pathogens. The initiative encompasses four key building blocks: strategic and operational frameworks, standardized assessment tools, a global AMR laboratory network, and research and innovation in diagnostics. 🔗 Read and download the document using this link: https://lnkd.in/e7xAZq9q __ #AMR #Diagnostics #WHO #Onehealth #LaboratorySystems #InfectiousDiseases #Surveillance #UHC #SDG

🦠Spotlight on Non-Tuberculous Mycobacteria (NTM) in Healthcare: Key Species, Risks, and Testing Tips🦠  Did you know that certain Non-Tuberculous Mycobacteria (NTM) species can pose serious health risks, especially to vulnerable individuals? NTMs are a diverse group of environmental mycobacteria found in soil, water, and biofilms. Unlike Mycobacterium tuberculosis, NTMs aren’t contagious, but they can thrive in healthcare settings where they can become a threat. Key species like Mycobacterium avium complex (MAC), M. abscessus, M. fortuitum, and M. kansasii, are opportunistic pathogens that inhabit moist, biofilm-prone areas such as water systems, sinks, and even medical equipment. When aerosolized, NTMs can lead to respiratory infections, particularly in immunocompromised patients, and may exacerbate chronic lung conditions. To reduce NTM exposure risks, routine environmental testing is critical. Regular sampling of water sources and biofilm inspection can help identify contamination hotspots. Consider consulting with an industrial hygienist or infection control specialist for tailored testing protocols and control strategies. 💬 **Is your facility proactive in NTM monitoring? Let’s discuss in the comments!** 👇 #InfectionControl #HealthcareSafety #NTM #EnvironmentalTesting #InfectionPrevention #EnvironmentalHealth Get In Touch: ☎️ 905-290-9101 📧 info@moldbacteria.com 🌎 www.moldbacteria.com 📸 @moldbacteria

"🌐 Discover How Microbiomes Connect Us All! Join the global conversation at the Microbiome Conference and be part of the future of science. #Microbiome2025" 🌍 Antimicrobial Resistance: A Global Health Crisis in the Making 🦠 Antimicrobial resistance (AMR) is one of the biggest threats to global health today. Misuse and overuse of antibiotics and other antimicrobials in humans, animals, and agriculture are accelerating this phenomenon, leading to infections that are harder to treat and more costly. 🚨 What can we do? Promote responsible use of antibiotics in healthcare and agriculture. Strengthen infection prevention and control measures. Support research for new antibiotics and alternatives. 🗓 May,12-13,2025 Paris, France Website: https://lnkd.in/gXrt2YSh #GMC2025 #Microbiome #Hybriedevents #Globalcongress

Did you know that "several studies suggest far-field transmission (>6 ft) explains a significant number of COVID-19 superspreading outbreaks"? This brand-new study "suggests that for rooms with similar airflow parameters disease transmission risk is dominated by near-field exposures for shorter event durations (e.g., initial 20–25-minutes of event) whereas far-field exposures are critical throughout the entire event and are increasingly more important for longer event durations." Congrats to co-authors Hooman parhizkar, Mark Fretz, Aurélie Laguerre, Jason Stenson, Richard Corsi, Kevin Van Den Wymelenberg & Elliott Gall! Read the brand-new Open-Access article online now: https://lnkd.in/eVRQVp8p #COVID19 #Transmission #Airflow #OpenAccess

Great to see the WHO AMR Diagnostic Initiative Policy brief. Kudos to Lusubilo Malakibungu and team for publishing this important work. The report identifies 4 important pillars that as a foundation demonstrate the importance of ensuring greater access to, and importantly, utilization to diagnostics. Far too often diagnostics are under-utilized leading to the inappropriate use of antibiotics. Policies are needed to not only strengthen lab capacity and surveillance, but also ensure health systems are using the diagnostics already accessible to providers. #AMR #diagnosticsispower

G7 Summit 13-14-15 June Apulia G7 Leaders’ Communiqué "We remain deeply concerned with antimicrobial resistance (AMR) and other health challenges exacerbated by the triple planetary crisis of climate change, biodiversity loss and pollution, including in low and middle-income countries. Ahead of the UNGA High-Level Meeting on AMR in September 2024, we will support an ambitious outcome document that champions the needs of low- and middle-income countries and include concrete goals and targets that galvanize action alongside the mandate for an evidence-based panel to continue to drive action on AMR. We will continue promoting equitable access to essential antibiotics and integrated actions to counter AMR within a One Health Framework, by exploring and implementing infection prevention and control measures, as well as exercising stewardship for prudent and appropriate use of antimicrobials, including surveillance of their use and consumption. We will also implement push and pull incentives, support public-private partnerships and explore innovative instruments to accelerate research and development on new antimicrobials, their alternatives, and diagnostics."  https://lnkd.in/drhVeahd

#AMR has become world's largest health challenge of the 21st century. The G7 statement reiterates it once again and HLM meetings in NY and RYAD also will issue their own official statement along the same lines. Now the G7 countries (not only) should drive this effort forward by taking concrete steps to fulfill the commitments they made in their joint declaration. But what can we do about it? The generic indication that we need “stronger” or “more effective” antibiotics is just a declaration of purpose. #AMR is not a disease, it’s is an “exacerbation” of thens of infectious diseases caused by several microbes. And for each of them we need a specific antibiotic. But how long does it take to make an antibiotic available? And how long will its effectiveness last since bacteria now know how to become resistant? Maybe a different approach should be considered. Chemistry (antibiotics and several disinfectants) belongs to the past, in the fight against infections we must use solutions able to create environments where living beings and microbes can live together in a peaceful way. For this, to counteract microbial infections and AMR we cannot focus only on the research of new drugs but we have to use all new and existing technologies and NPI’s to reduce the risk of infections in everyday living spaces. Microbes are everywhere, we cannot live without them so we need to find a path of correct and peaceful coexistence with them. Now the first goal is to avoid reaching the “pathological situation” when we need drug by doing everything possible to prevent infections from spreading. And we need some effective solution now not in 5-10 years! I hope that this change of paradigm will enter as main topic in the general debate on AMR by affirming that AMR is not a surprise but is a foreseeable consequence of the abuse and misuse of the sanitising methods not compliant with natural ecosystem (like UVC and chemicals) and drugs (antibiotic too) that contains chemical elements that were not part of the world of microbes. For this bacteria consider all of them like enemies and since they have to survive we are now witnessing their revenge for their survival (as Fleming, Dormagk and others scientists had already predicted more than 50 years ago). Antibiotics saved millions of lives but know we know that they are no longer effective. Science and research also serve to understand when it is time to change the approach and for microbial infections perhaps that moment has come. #continuoussanitsation #cleanair #onehealth

Antimicrobial resistance (AMR) & Healthcare-associated Infections (HAIs) are two of the greatest threats to global health today. Pathogens are evolving, antibiotics are losing effectiveness, and healthcare systems are under immense pressure to keep up. Our dedicated team at H7 Technologies is addressing these challenges head-on with the power of UV-C technology—a proven, chemical-free method to eliminate AMR and reduce the risk of HAIs. ✅ Surface & Air Disinfection: Targeting high-risk zones in hospitals, ICUs, surgical suites, and diagnostic labs. ✅ Validated Pathogen Eradication: Effective against pathogens like MRSA, C. difficile, and Pseudomonas aeruginosa. ✅ Scalable Solutions: Designed for deployment across diverse settings such as healthcare, education, offices, public transit, and hospitality. But technology alone isn’t enough. This fight demands collaboration, innovation, and knowledge-sharing across disciplines. From phage therapy to novel antimicrobial agents and AI-powered diagnostics, the global scientific community is pushing boundaries to tackle this crisis. What innovative solutions have you encountered in the fight against antimicrobial resistance infections and HAIs? Let’s share insights, bridge gaps, and work together towards a future where infections are not just treated—but prevented. Comment your thoughts below or reach out—because every perspective brings us one step closer to a solution. #AntimicrobialResistance #AMR #Healthcare-associatedInfections #HAIs #InfectionPrevention #HealthcareInnovation #UVCTechnology #PatientSafety #GlobalHealth